Being able to own what you create has helped make the United States the global leader in innovation and entrepreneurship. As the federal agency tasked with managing our intellectual property ...
The United States Patent and Trademark Office recently issued patent 12,178,937 entitled “Compositions and Methods for ...
The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback